For: | de Moraes Andrade PV, Monteiro YM, Chehter EZ. Third-line and rescue therapy for refractory Helicobacter pylori infection: A systematic review. World J Gastroenterol 2023; 29(2): 390-409 [PMID: 36687120 DOI: 10.3748/wjg.v29.i2.390] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i2/390.htm |
Number | Citing Articles |
1 |
Maria Belen Justich, Olga L. Rojas, Alfonso Fasano. The Role of Helicobacter pylori and Small Intestinal Bacterial Overgrowth in Parkinson's Disease. Seminars in Neurology 2023; 43(04): 553 doi: 10.1055/s-0043-1771468
|
2 |
Chia-Jung Kuo, Ngoc-Niem Bui, Jun-Nong Ke, Cheng-Yu Lin, Wey-Ran Lin, Ming-Ling Chang, Hui-Yu Wu, Mei-Zi Huang, Cheng-Hsun Chiu, Cheng-Tang Chiu, Chih-Ho Lai. Molecular characterization of rifabutin-resistance in refractory Helicobacter pylori infection in Taiwan. International Journal of Infectious Diseases 2024; 138: 25 doi: 10.1016/j.ijid.2023.11.001
|
3 |
Joseph Edwin Kanu, Jonathan Soldera. Treatment of <i>Helicobacter pylori</i> with potassium competitive acid blockers: A systematic review and meta-analysis. World Journal of Gastroenterology 2024; 30(9): 1213-1223 doi: 10.3748/wjg.v30.i9.1213
|
4 |
Claudiu T. Supuran.
Novel carbonic anhydrase inhibitors for the treatment of
Helicobacter pylori
infection
. Expert Opinion on Investigational Drugs 2024; : 1 doi: 10.1080/13543784.2024.2334714
|